Literature DB >> 18476935

Octreotide in children with hypoglycaemia due to sulfonylurea ingestion.

Shoshana Rath, Naor Bar-Zeev, Kym Anderson, Rosemary Fahy, Rob Roseby.   

Abstract

Sulfonylureas are commonly prescribed for type 2 diabetes mellitus; however, overdose or accidental ingestion may result in profound and prolonged hypoglycaemia with permanent neurological sequelae and death. We describe two cases of children with hypoglycaemia due to presumed accidental ingestion of sulfonylureas, where traditional methods of raising blood sugar levels were unsatisfactory. Two studies describe Octreotide for adults with hypoglycaemia, but there are no studies examining the use of Octreotide in children for this indication. Given that Octreotide has been shown to be safe in children when used for other indications, we used Octreotide to safely restore euglycaemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18476935     DOI: 10.1111/j.1440-1754.2008.01339.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  4 in total

1.  Unwitnessed sulphonylurea poisoning in a healthy toddler.

Authors:  Pei Ying Loo; Fabian Yap
Journal:  Eur J Pediatr       Date:  2010-05-15       Impact factor: 3.183

Review 2.  Octreotide's role in the management of sulfonylurea-induced hypoglycemia.

Authors:  Patrick P Dougherty; Wendy Klein-Schwartz
Journal:  J Med Toxicol       Date:  2010-06

Review 3.  Drugs and pharmaceuticals: management of intoxication and antidotes.

Authors:  Silas W Smith
Journal:  EXS       Date:  2010

Review 4.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.